INTERCURE LTD. Inactive Instrument
InterCure Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
INCR
IL0011063760
Healthcare Facilities & Services
| Sales 2021 | 219.68 830.38 | Sales 2022 | 388.68 1.47K | Capitalization | 551M 2.08B |
|---|---|---|---|---|---|
| Net income 2021 | 4M 15.12M | Net income 2022 | 44M 166M | EV / Sales 2021 | 3,844,919 x |
| Net cash position 2021 | 87.64M 331M | Net Debt 2022 | 22.37M 84.54M | EV / Sales 2022 | 1,473,908 x |
| P/E ratio 2021 |
207
x | P/E ratio 2022 |
12.2
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 64.2% |
More Fundamentals
* Assessed data
More news
Latest transcript on InterCure Ltd.
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 18-09-30 | |
Amos Cohen
DFI | Director of Finance/CFO | 45 | 20-02-29 |
Boaz Lahav
SAM | Sales & Marketing | - | 22-10-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ehud Barak
CHM | Chairman | 81 | 18-08-31 |
| Chief Executive Officer | 53 | 18-09-30 | |
| Director/Board Member | 62 | 20-10-31 |
InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +39.92% | 272M | |
| +34.02% | 276M | |
| -31.48% | 141M | |
| +46.52% | 133M | |
| -42.86% | 96.23M | |
| +7.69% | 93.09M | |
| +150.00% | 75.33M | |
| +37.50% | 63.28M | |
| +4.82% | 56.96M |
